Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ecovyst is a leading global provider of specialty catalysts and services, primarily serving the energy, chemicals, and life sciences sectors. The company operates through two core segments: Ecoservices, which provides sulfuric acid recycling and logistics, and Catalyst Technologies, which develops high-performance silica catalysts and zeolites. In the healthcare and life sciences space, Ecovyst's products are utilized as essential catalysts in pharmaceutical synthesis and as ingredients in personal care and dental products. Formerly known as PQ Group Holdings, the company rebranded in 2021 to focus on its high-growth catalyst and sustainability-focused businesses. The company is a key player in the circular economy through its extensive sulfuric acid regeneration services and is publicly traded on the New York Stock Exchange.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ecovyst.